In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease.
Quentin LandolffMarine QuillotFabien PicardPatrick HenryGeorgios SiderisOlivier BizeauChristophe PiotBernard JouveJérôme RischnerMourad MejriClaude CharmassonRaphael LasserreHervé PouliquenThierry JosephJacques MonseguBernard KarsentyVictoria Martin YusteNicolas RichetGuy LapeyreFabrizio BeverelliFarzin BeyguiRené KoningPublished in: Journal of interventional cardiology (2023)
The latest generation PF-SES is associated with low clinical event rates in these all-comers patients. There was a high rate of prematurely terminated DAPT, without any effect on MACE at 12 months. This trial is registered with NCT03809715.
Keyphrases
- acute coronary syndrome
- coronary artery disease
- end stage renal disease
- percutaneous coronary intervention
- newly diagnosed
- antiplatelet therapy
- ejection fraction
- healthcare
- clinical trial
- peritoneal dialysis
- prognostic factors
- cardiovascular disease
- type diabetes
- emergency department
- patient reported outcomes
- phase iii
- phase ii
- patient reported
- aortic valve
- transcatheter aortic valve replacement
- open label
- acute care